Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 162

1.

Impact of measles elimination activities on immunization services and health systems: findings from six countries.

Hanvoravongchai P, Mounier-Jack S, Oliveira Cruz V, Balabanova D, Biellik R, Kitaw Y, Koehlmoos T, Loureiro S, Molla M, Nguyen H, Ongolo-Zogo P, Sadykova U, Sarma H, Teixeira M, Uddin J, Dabbagh A, Griffiths UK.

J Infect Dis. 2011 Jul;204 Suppl 1:S82-9. doi: 10.1093/infdis/jir091.

2.

Impact of measles eradication activities on routine immunization services and health systems in Bangladesh.

Koehlmoos TP, Uddin J, Sarma H.

J Infect Dis. 2011 Jul;204 Suppl 1:S90-7. doi: 10.1093/infdis/jir086.

3.

How can measles eradication strengthen health care systems?

Griffiths UK, Mounier-Jack S, Oliveira-Cruz V, Balabanova D, Hanvoravongchai P, Ongolo P.

J Infect Dis. 2011 Jul;204 Suppl 1:S78-81. doi: 10.1093/infdis/jir090.

4.

South-East Asia Regional update on measles mortality reduction and elimination, 2003-2008.

O'Connor PM, Liyanage JB, Mach O, Anand A, Ramamurty N, Balakrishnan MR, Singh S.

J Infect Dis. 2011 Jul;204 Suppl 1:S396-402. doi: 10.1093/infdis/jir085.

5.

Interruption of measles transmission in Brazil, 2000-2001.

Prevots DR, Parise MS, Segatto TC, Siqueira MM, dos Santos ED, Ganter B, Perreira MC, Domingues CA, Lanzieri T, Da Silva JB Jr.

J Infect Dis. 2003 May 15;187 Suppl 1:S111-20. Review.

6.

The challenge of achieving measles elimination in the eastern Mediterranean region by 2010.

Gaafar T, Moshni E, Lievano F.

J Infect Dis. 2003 May 15;187 Suppl 1:S164-71.

7.

Assessing the cost-effectiveness of measles elimination in Uganda: local impact of a global eradication program.

Babigumira JB, Levin A, Burgess C, Garrison LP Jr, Bauch CT, Braka F, Mbabazi WB, Nabyonga JO, Simons E, Dabbagh A.

J Infect Dis. 2011 Jul;204 Suppl 1:S116-23. doi: 10.1093/infdis/jir132.

8.

Research priorities for global measles and rubella control and eradication.

Goodson JL, Chu SY, Rota PA, Moss WJ, Featherstone DA, Vijayaraghavan M, Thompson KM, Martin R, Reef S, Strebel PM.

Vaccine. 2012 Jul 6;30(32):4709-16. doi: 10.1016/j.vaccine.2012.04.058. Epub 2012 Apr 28.

PMID:
22549089
9.

Accelerated measles control in the Western Pacific region.

McFarland JW, Mansoor OD, Yang B.

J Infect Dis. 2003 May 15;187 Suppl 1:S246-51. Review.

10.

Measles control in Sub-Saharan Africa: South Africa as a case study.

Verguet S, Jassat W, Hedberg C, Tollman S, Jamison DT, Hofman KJ.

Vaccine. 2012 Feb 21;30(9):1594-600. doi: 10.1016/j.vaccine.2011.12.123. Epub 2012 Jan 9.

PMID:
22230581
11.

Progress in global measles control and mortality reduction, 2000-2006.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2007 Nov 30;56(47):1237-41.

12.

Can measles be eradicated globally?

de Quadros CA.

Bull World Health Organ. 2004 Feb;82(2):134-8. Epub 2004 Mar 16.

13.
14.

Should outbreak response immunization be recommended for measles outbreaks in middle- and low-income countries? An update.

Cairns KL, Perry RT, Ryman TK, Nandy RK, Grais RF.

J Infect Dis. 2011 Jul;204 Suppl 1:S35-46. doi: 10.1093/infdis/jir072. Review.

15.

Global measles control and regional elimination, 1998-1999.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 1999 Dec 17;48(49):1124-30.

16.

Progress toward the 2012 measles elimination goal--Western Pacific Region, 1990-2008.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2009 Jun 26;58(24):669-73.

17.

Effects of measles-control activities--African region, 1999-2005.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2006 Sep 22;55(37):1017-21.

18.

What will it take to achieve measles elimination in the World Health Organization European Region: progress from 2003-2009 and essential accelerated actions.

Martin R, Wassilak S, Emiroglu N, Uzicanin A, Deshesvoi S, Jankovic D, Goel A, Khetsuriani N.

J Infect Dis. 2011 Jul;204 Suppl 1:S325-34. doi: 10.1093/infdis/jir137.

19.

Measles outbreaks and progress toward measles preelimination --- African region, 2009-2010.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2011 Apr 1;60(12):374-8.

20.

Measles supplementary immunization activities and GAVI funds as catalysts for improving injection safety in Africa.

Hoekstra EJ, van den Ent MM, Dao H, Khalaf H, Salovaara A.

J Infect Dis. 2011 Jul;204 Suppl 1:S190-7. doi: 10.1093/infdis/jir073.

Items per page

Supplemental Content

Write to the Help Desk